The decisions made at the NENC Medicines Subcommittee April 2023 meeting can now be found at:

This includes the recommendations made by NTAG in March 2023 meeting and NICE Technology appraisals from the 1st January 2023 to 31st January 2023.

The following guidelines/position statements were approved and can be found at:
• NENC regional guidance On SGLT2 inhibitors – supersedes previous versions for CKD, heart failure and type 2 diabetes

• NENC ICB position statement – nonpalliative care use of opiates

Drugs with a NICE recommendation published in February and March 2023 have been considered by NTAG in its May meeting, and will be considered for approval by Medicines Subcommittee at its June 2023 meeting.

All approved NENC Medicines Subcommittee and NTAG meeting minutes can be found at: and